Showing results (21-30 of 208) with videos related to
Sort By:
Pageof 21
American Journal of Nephrology|August 1, 2015
Low Bone Turnover in Chronic Kidney Disease Is Associated with Decreased VEGF-A Expression and Osteoblast DifferentiationNeal X Chen, Kalisha D O'Neill, Matthew R Allen, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2002
Cellular uptake of beta2M and AGE-beta2M in synovial fibroblasts and macrophagesKalisha D O'Neill, Neal X Chen, Mu Wang, et al.American Journal of Nephrology|March 8, 2013
Transglutaminase 2 accelerates vascular calcification in chronic kidney diseaseNeal X Chen, Kalisha O'Neill, Xianming Chen, et al.Bone Reports|June 30, 2018
Skeletal vascular perfusion is altered in chronic kidney diseaseMohammad W Aref, Elizabeth A Swallow, Neal X Chen, et al.Plos One|June 27, 2015
Differential miRNA Expression in Cells and Matrix Vesicles in Vascular Smooth Muscle Cells from Rats with Kidney DiseasePraneet Chaturvedi, Neal X Chen, Kalisha O'Neill, et al.JBMR Plus|December 12, 2024
The uremic toxin indoxyl sulfate decreases osteocyte RANKL/OPG and increases Wnt inhibitor RNA expression that is reversed by PTHNeal X Chen, Kalisha D O'Neill, Hannah E Wilson, et al.American Journal of Nephrology|July 28, 2011
Activation of arterial matrix metalloproteinases leads to vascular calcification in chronic kidney diseaseNeal X Chen, Kalisha D O'Neill, Xianming Chen, et al.Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|March 9, 2019
Phosphate Binders and Nonphosphate Effects in the Gastrointestinal TractAnnabel Biruete, Kathleen M Hill Gallant, Stephen R Lindemann, et al.Bone|April 21, 2015
Compromised vertebral structural and mechanical properties associated with progressive kidney disease and the effects of traditional pharmacological interventionsChristopher L Newman, Neal X Chen, Eric Smith, et al.Bone|January 27, 2022
Cortical porosity development and progression is mitigated after etelcalcetide treatment in an animal model of chronic kidney diseaseElizabeth A Swallow, Corinne E Metzger, Christopher L Newman, et al.Pageof 21